Previous 10 | Next 10 |
Collegium Pharmaceutical has seen a decent 2021, but starts 2022 with a big and interesting deal. Investors are highly attracted to diversification and in anticipation of huge synergies. This looks compelling, yet the earnings situation will likely become complicated for quite a w...
NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: US Ecology, Inc. (NASDAQ:ECOL)'s...
According to an article published by Bloomberg (1), the world may face a massive shortfall of what’s arguably the most critical metal for global economies: copper. The copper industry needs to spend upwards of $100 billion to close what could be an annual supply deficit of 4.7 million ...
Collegium Pharmaceutical is acquiring BioDelivery Sciences for $5.60 per share in an all cash offer. I argue why the deal is good, but not great for BioDelivery Sciences. We take a cursory look at Collegium Pharmaceutical. For further details see: BioDelivery Sciences Bu...
Worries about Ukraine and Federal Reserve policy led to an uncertain session on Monday, with the Dow and S&P 500 posting modest losses. The Nasdaq finished the day just below the unchanged mark. While the overall market failed to find significant buying interest, electric vehicle stocks m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s market is BioDelivery Sciences (NASDAQ: BDSI ). At the time of writing, BDSI stock has surged more than 50% higher on incredible volume. This move comes, as many would expec...
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) and BioDelivery Sciences International Inc. (NASDAQ: BDSI) have announced a definitive agreement where Collegium will acquire BDSI for USD 5.60 per share in cash. BDSI holds a portfolio of pain and neurology products ...
Gainers: BioDelivery Sciences International (NASDAQ:BDSI) +52%. Knightscope (NASDAQ:KSCP) +31%. Ebang International (NASDAQ:EBON) +22%. Cornerstone Building Brands (NYSE:CNR) +22%. Kelly Services (NASDAQ:KELYA) +18%. NRx Pharmaceuticals (NASDAQ:NRXP) +17%. Cadiz (NASDAQ:CDZI) +...
Stocks weren't able to mount a convincing recovery on Monday morning after facing steep volatility toward the end of last week. As of 10 a.m. ET today, the Dow Jones Industrial Average (DJINDICES: ^DJI) was down 295 points to 34,443. The S&P 500 (SNPINDEX: ^GSPC) had los...
MONSEY, N.Y., Feb. 14, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI”) acted in the best interests of BDSI shareholders in approving the sale of BDSI to ...
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...